186 related articles for article (PubMed ID: 2981838)
21. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the vasoactive intestinal peptide (VIP) binding sites: a biochemical and an immunological approach.
Marvaldi J; Luis J; Muller JM; el Battari A; Fantini J; Martin JM; Abadie B; Tirard A; Pichon J
Peptides; 1986; 7 Suppl 1():137-45. PubMed ID: 3018691
[TBL] [Abstract][Full Text] [Related]
23. Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.
Martin JM; Darbon H; Luis J; el Battari A; Marvaldi J; Pichon J
Biochem J; 1988 Mar; 250(3):679-85. PubMed ID: 2839143
[TBL] [Abstract][Full Text] [Related]
24. Evidence for vasoactive intestinal peptide receptors in apical membranes from tracheal epithelium.
Elgavish A; Pillion DJ; Meezan E
Life Sci; 1989; 44(15):1037-42. PubMed ID: 2538697
[TBL] [Abstract][Full Text] [Related]
25. Molecular characteristics and evidence for internalization of vasoactive-intestinal-peptide (VIP) receptors in the tumoral rat-pancreatic acinar cell line AR 4-2 J.
Svoboda M; De Neef P; Tastenoy M; Christophe J
Eur J Biochem; 1988 Oct; 176(3):707-13. PubMed ID: 2844535
[TBL] [Abstract][Full Text] [Related]
26. Vasoactive intestinal peptide receptor on liver plasma membranes: characterization as a glycoprotein.
Nguyen TD; Williams JA; Gray GM
Biochemistry; 1986 Jan; 25(2):361-8. PubMed ID: 3006758
[TBL] [Abstract][Full Text] [Related]
27. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung.
Dickinson KE; Schachter M; Miles CM; Coy DH; Sever PS
Peptides; 1986; 7(5):791-800. PubMed ID: 3025822
[TBL] [Abstract][Full Text] [Related]
28. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
Sakakibara H; Shima K; Said SI
Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
[TBL] [Abstract][Full Text] [Related]
29. Species differences in the molecular characteristics of vasoactive-intestinal-peptide receptors in the pancreas from rat and guinea-pig.
Svoboda M; Poloczek P; Winand J; Robberecht P; Christophe J
Eur J Biochem; 1988 May; 174(1):59-66. PubMed ID: 2836201
[TBL] [Abstract][Full Text] [Related]
30. Covalent labeling of the somatostatin receptor in rat anterior pituitary membranes.
Bruno JF; Berelowitz M
Endocrinology; 1989 Feb; 124(2):831-7. PubMed ID: 2563243
[TBL] [Abstract][Full Text] [Related]
31. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
Luis J; Martin JM; el Battari A; Reynier M; Marvaldi J; Pichon J
Eur J Biochem; 1989 Mar; 180(2):429-33. PubMed ID: 2538330
[TBL] [Abstract][Full Text] [Related]
32. Use of the heterobifunctional cross-linker m-maleimidobenzoyl N-hydroxysuccinimide ester to affinity label cholecystokinin binding proteins on rat pancreatic plasma membranes.
Madison LD; Rosenzweig SA; Jamieson JD
J Biol Chem; 1984 Dec; 259(23):14818-23. PubMed ID: 6094576
[TBL] [Abstract][Full Text] [Related]
33. Structural characterization of Y1 and Y2 receptors for neuropeptide Y and peptide YY by affinity cross-linking.
Sheikh SP; Williams JA
J Biol Chem; 1990 May; 265(14):8304-10. PubMed ID: 2159475
[TBL] [Abstract][Full Text] [Related]
34. Characterization of vasoactive intestinal peptide receptors in rabbit ciliary processes.
Horio B; Law NM; Rosenzweig SA
Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):192-9. PubMed ID: 7529752
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization and peptide specificity of two vasoactive intestinal peptide (VIP) binding sites in the chicken pineal.
Meunier AC; Voisin P; Van Camp G; Cenatiempo Y; Muller JM
Neuropeptides; 1991 May; 19(1):1-8. PubMed ID: 1653910
[TBL] [Abstract][Full Text] [Related]
36. Covalent cross-linking of growth hormone-releasing factor to pituitary receptors.
Veliçelebi G; Patthi S; Provow S; Akong M
Endocrinology; 1986 Apr; 118(4):1278-83. PubMed ID: 3004907
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of receptors for VIP in rat peritoneal macrophage membranes.
Calvo JR; Guerrero JM; López-Gonzalez MA; Osuna C; Segura JJ
Peptides; 1994; 15(2):309-15. PubMed ID: 8008637
[TBL] [Abstract][Full Text] [Related]
38. Binding characteristics and affinity labeling of protein constituents of the human IM-9 lymphoblast receptor for substance P.
Payan DG; McGillis JP; Organist ML
J Biol Chem; 1986 Oct; 261(30):14321-9. PubMed ID: 2429956
[TBL] [Abstract][Full Text] [Related]
39. Affinity labeling of a nerve growth factor receptor component on rat pheochromocytoma (PC12) cells.
Massague J; Buxser S; Johnson GL; Czech MP
Biochim Biophys Acta; 1982 Dec; 693(1):205-12. PubMed ID: 6295482
[TBL] [Abstract][Full Text] [Related]
40. Characterization and affinity cross-linking of receptors for human recombinant lymphotoxin (tumor necrosis factor-beta) on a human histiocytic lymphoma cell line, U-937.
Stauber GB; Aggarwal BB
J Biol Chem; 1989 Feb; 264(6):3573-6. PubMed ID: 2536752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
